Co-Diagnostics, Inc. (CODX) Q4 2024 Annual Earnings
CODX·Reported March 27, 2025·After market close
Co-Diagnostics, Inc. reported Q4 2024 revenue of $149.3K, missed analyst consensus of $375.0K by $225.7K. Diluted EPS came in at $-0.36, missed the $-0.34 consensus by $0.02.
Revenue
$149.3Kmissed by $225.7K
Consensus: $375.0KDiluted EPS
$-0.36missed by $0.02
Consensus: $-0.34
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Co-Diagnostics, Inc. 's Q4 2024 earnings report.
Co-Diagnostics, Inc. (CODX) reported Q4 2024 earnings on March 27, 2025 after market close.
Co-Diagnostics, Inc. reported revenue of $149.3K and diluted EPS of $-0.36 for Q4 2024.
Revenue missed the consensus estimate of $375.0K by $225.7K. EPS missed the consensus estimate of $-0.34 by $0.02.
You can read the 10-K periodic report (0001641172-25-000932) directly on SEC EDGAR. The filing index links above go to sec.gov.